Skip to main content
SpringerLink
Log in

Pharmaconutrition in the Critically Ill Patient

  • Chapter
  • First Online:
Metabolic Disorders and Critically Ill Patients

  • 1661 Accesses

Abstract

Critically ill patients might benefit from specialized nutrients provided in addition to macro- and micronutrients. Initially, the theoretical basis for specialized nutrition support relates to the altered immune response associated with the prolonged inflammatory status. For instance, immune-enhancing or immune-modulating nutrition formulas have been considered as logical and attractive options in critically ill patients [1]. Subsequently, changes in the composition of nutritional formulas were brought to compensate for specific deficiencies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Dupertuis YM, Meguid MM, Pichard C (2009) Advancing from immunonutrition to a pharmaconutrition: a gigantic challenge. Curr Opin Clin Nutr Metab Care 12:398–403

    Article  CAS  PubMed  Google Scholar 

  2. Heys SD, Schofield AC, Wahle KW (2004) Immunonutrition in clinical practice: what is the current evidence? Nutr Hosp 19:325–332

    CAS  PubMed  Google Scholar 

  3. Heyland DK (2002) Immunonutrition in the critically ill patient: putting the cart before the horse? Nutr Clin Pract 17:267–272

    Article  PubMed  Google Scholar 

  4. Marik PE, Zaloga GP (2008) Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 34:1980–1990

    Article  PubMed  Google Scholar 

  5. Beale RJ, Bryg DJ, Bihari DJ (1999) Immunonutrition in the critically ill: a systematic review on clinical outcome. Crit Care Med 27:2799–2805

    Article  CAS  PubMed  Google Scholar 

  6. Montejo JC, Zarazaga A, López-Martínez J et al (2003) Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 22:221–233

    Article  PubMed  Google Scholar 

  7. Heyland DK, Novak F, Drover JW et al (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 22-29:944–953

    Article  Google Scholar 

  8. McClave SA, Martindale RG, Vanek VW et al (2009) Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) J Parenter Enter Nutr 33:277–316

    Article  Google Scholar 

  9. Preiser JC (2012) Oxidative stress. J Parenter Enter Nutr 36:147–154

    Article  CAS  Google Scholar 

  10. Preiser JC, Wernerman J (2003) Glutamine, a life-saving nutrient, but why? Crit Care Med 31:2555–2556

    Article  PubMed  Google Scholar 

  11. Oudemans-van Straaten HM, Bosman RJ, Treskes M et al (2001) Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 27:84–90

    Article  CAS  PubMed  Google Scholar 

  12. Griffiths RD, Jones C, Palmer TEA (1997) Six month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13:295–302

    CAS  PubMed  Google Scholar 

  13. Goeters C, Wenn A, Mertes N et al (2002) Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 30:2032–2037

    Article  CAS  PubMed  Google Scholar 

  14. Griffiths RD, Allen KD, Andrews FJ et al (2002) Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition 18:546–552

    Article  CAS  PubMed  Google Scholar 

  15. Dechelotte P, Hasselmann M, Cynober L et al (2006) L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 34:598–604

    Article  CAS  PubMed  Google Scholar 

  16. Garrel D, Patenaude J, Nedelec B et al (2003) Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med 31:2444–2449

    Article  CAS  PubMed  Google Scholar 

  17. Zhou YP, Jiang ZM, Sun YH et al (2003) The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. J Parenter Enter Nutr 27:241–245

    Article  CAS  Google Scholar 

  18. Peng X, Yan H, You Z et al (2004) Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns 30:135–139

    Article  PubMed  Google Scholar 

  19. Houdijk AP, Rijnsburger ER, Jansen J et al (1998) Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 352:772–776

    Article  CAS  PubMed  Google Scholar 

  20. Hall JC, Dobb G, Hall J et al (2003) Prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med 29:1710–1716

    Article  PubMed  Google Scholar 

  21. Heyland D, Muscedere J, Wischmeyer PE et al (2013) A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368:1489–1497

    Article  CAS  PubMed  Google Scholar 

  22. Lefrant JY, Hurel D, Cano NJ et al (2014) Guidelines for nutrition support in critically ill patient. Ann Fr Anesth Reanim 33(3):202–218

    Article  PubMed  Google Scholar 

  23. Mesejo A, Vaquerizo Alonso C, Acosta Escribano J et al (2011) Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE). Nutr Hosp 26(Suppl 2):1–85

    PubMed  Google Scholar 

  24. Bansal V, Ochoa JB (2003) Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 6:223–228

    Article  CAS  PubMed  Google Scholar 

  25. Vermeulen MA, van de Poll MC, Ligthart-Melis GC et al (2007) Specific amino acids in the critically ill patient—exogenous glutamine/arginine: a common denominator? Crit Care Med 35:S568–S576

    Article  CAS  PubMed  Google Scholar 

  26. Chiarla C, Giovannini I, Siegel JH (2006) Plasma arginine correlations in trauma and sepsis. Amino Acids 30:81–86

    Article  CAS  PubMed  Google Scholar 

  27. Druml W, Heinzel G, Kleinberger G (2001) Amino acid kinetics in patients with sepsis. Am J Clin Nutr 73:908–913

    CAS  PubMed  Google Scholar 

  28. Luiking YC, Poeze M, Ramsay G et al (2009) Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr 89:142–152

    Article  CAS  PubMed  Google Scholar 

  29. Stechmiller JK, Childress B, Porter T (2004) Arginine immunonutrition in critically ill patients: a clinical dilemma. Am J Crit Care 13:17–23

    PubMed  Google Scholar 

  30. Waitzberg DL, Torrinhas RS (2009) Fish oil lipid emulsions and immune response: what clinicians need to know. Nutr Clin Pract 24:487–499

    Article  PubMed  Google Scholar 

  31. Heller AR, Rössler S, Litz RJ (2006) Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 34:972–979

    Article  CAS  PubMed  Google Scholar 

  32. Tsekos E, Reuter C, Stehle P et al (2004) Perioperative administration of fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr 23:325–330

    Article  CAS  PubMed  Google Scholar 

  33. Gadek JE, DeMichele SJ, Karlstad MD et al (1999) Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med 27:1409–1420

    Article  CAS  PubMed  Google Scholar 

  34. Singer P, Theilla M, Fisher H et al (2006) Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 34:1033–1038

    Article  CAS  PubMed  Google Scholar 

  35. Pontes-Arruda A, Aragão AM, Albuquerque JD (2006) Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 34:2325–2333

    Article  CAS  PubMed  Google Scholar 

  36. Pontes-Arruda A, DeMichele S, Seth A et al (2008) The use of an inflammation modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis evaluation of outcome data. J Parenter Enter Nutr 32:596–605

    Article  CAS  Google Scholar 

  37. Preiser JC (2008) Nutrition therapy for the acute respiratory distress syndrome. J Parenter Enter Nutr 32:669–670

    Article  Google Scholar 

  38. Goodyear-Bruch C, Pierce JD (2002) Oxidative stress in critically ill patients. Am J Crit Care 11:543–551

    PubMed  Google Scholar 

  39. Lovat R, Preiser JC (2003) Antioxidant therapy in intensive care. Curr Opin Crit Care 9:266–270

    Article  PubMed  Google Scholar 

  40. Motoyama T, Okamoto K, Kukita I et al (2003) Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31:1048–1052

    Article  CAS  PubMed  Google Scholar 

  41. Alonso de Vega JM, Diaz J, Serrano E, Carbonell LF (2002) Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 30:1782–1786

    Article  PubMed  Google Scholar 

  42. Preiser JC, Van Gossum A, Berre J et al (2000) Enteral feeding with a solution enriched with antioxidant vitamins A, C, and E enhances the resistance to oxidative stress. Crit Care Med 28:3828–3832

    Article  CAS  PubMed  Google Scholar 

  43. Nathens AB, Neff MJ, Jurkovich GJ et al (2002) Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 236:814–822

    Article  PubMed  PubMed Central  Google Scholar 

  44. Crimi E, Liguori A, Condorelli M et al (2004) The beneficial effects of antioxidant supplementation in enteral feeding in critically ill patients: a prospective, randomized, double-blind, placebo-controlled trial. Anesth Analg 99:857–863

    Article  CAS  PubMed  Google Scholar 

  45. Berger MM, Shenkin A (1998) Trace elements in trauma and burns. Curr Opin Clin Nutr Metab Care 1:513–517

    Article  CAS  PubMed  Google Scholar 

  46. Berger MM, Chiolero RL (2007) Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 35:S584–S590

    Article  CAS  PubMed  Google Scholar 

  47. Angstwurm MW, Engelmann L, Zimmermann T et al (2007) Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35:118–126

    Article  CAS  PubMed  Google Scholar 

  48. Singer P, Berger MM, Van den Berghe G et al (2009) ESPEN guidelines in parenteral nutrition: Intensive Care. Clin Nutr 28:387–400

    Article  PubMed  Google Scholar 

  49. Kreymann KG, Berger MM, Deutz NEP et al (2006) ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr 25:210–223

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care, Erasme University Hospital, 1070, Brussels, Belgium

    Jean-Charles Preiser & Carlos A. Santacruz

  2. Department of dietetics, University Hospital of Liege, Liege, Belgium

    Christian Malherbe

Authors
  1. Jean-Charles Preiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Malherbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carlos A. Santacruz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Charles Preiser .

Editor information

Editors and Affiliations

  1. Intensive Care Unit, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, France

    Carole Ichai

  2. Intensive Care Unit, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, France

    Hervé Quintard

  3. Intensive Care Unit, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, France

    Jean-Christophe Orban

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Preiser, JC., Malherbe, C., Santacruz, C.A. (2018). Pharmaconutrition in the Critically Ill Patient. In: Ichai, C., Quintard, H., Orban, JC. (eds) Metabolic Disorders and Critically Ill Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-64010-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64010-5_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64008-2

  • Online ISBN: 978-3-319-64010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation